DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,239,247 | -21.0% | 981,059 | +13.1% | 0.01% | -14.3% |
| Q2 2023 | $25,603,791 | +32.9% | 867,631 | +3.7% | 0.01% | +16.7% |
| Q1 2023 | $19,268,997 | -17.2% | 836,328 | -0.0% | 0.01% | -14.3% |
| Q4 2022 | $23,267,876 | +3.7% | 836,673 | +14.5% | 0.01% | -12.5% |
| Q3 2022 | $22,431,000 | +4.2% | 730,880 | -0.1% | 0.01% | +14.3% |
| Q2 2022 | $21,530,000 | -5.0% | 731,522 | +3.9% | 0.01% | 0.0% |
| Q1 2022 | $22,656,000 | -29.2% | 704,251 | -1.8% | 0.01% | -22.2% |
| Q4 2021 | $31,987,000 | -9.9% | 717,190 | +1.9% | 0.01% | -25.0% |
| Q3 2021 | $35,505,000 | -29.3% | 703,752 | +9.9% | 0.01% | -29.4% |
| Q2 2021 | $50,220,000 | +55.5% | 640,234 | +13.2% | 0.02% | +41.7% |
| Q1 2021 | $32,291,000 | -21.8% | 565,516 | +14.7% | 0.01% | -25.0% |
| Q4 2020 | $41,311,000 | +137.0% | 493,198 | +1.4% | 0.02% | +100.0% |
| Q3 2020 | $17,430,000 | +53.0% | 486,440 | +3.2% | 0.01% | +33.3% |
| Q2 2020 | $11,395,000 | +55.4% | 471,246 | +12.6% | 0.01% | +50.0% |
| Q1 2020 | $7,331,000 | +12.4% | 418,672 | +11.8% | 0.00% | 0.0% |
| Q4 2019 | $6,524,000 | +15.9% | 374,478 | +2.0% | 0.00% | +33.3% |
| Q3 2019 | $5,627,000 | -23.2% | 367,275 | +4.0% | 0.00% | -25.0% |
| Q2 2019 | $7,331,000 | -6.8% | 353,122 | +4.3% | 0.00% | -20.0% |
| Q1 2019 | $7,864,000 | +18.1% | 338,647 | +5.1% | 0.01% | 0.0% |
| Q4 2018 | $6,658,000 | -5.7% | 322,264 | -0.8% | 0.01% | 0.0% |
| Q3 2018 | $7,063,000 | +482.3% | 324,841 | +308.5% | 0.01% | +400.0% |
| Q2 2018 | $1,213,000 | -7.0% | 79,529 | +20.1% | 0.00% | 0.0% |
| Q1 2018 | $1,304,000 | – | 66,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |